IP Verse

Compositions And Methods For Tcr Reprogramming Using Fusion Proteins - EP3298033

PATENT ANALYSIS

Patent Details

Grant Date
Jul 12, 2023
Company
TCR2 THERAPEUTICS INC.
Oppositions

JONES DAY

More patents of Tcr2 Therapeutics Inc.

EP3298033

Want to monitor this patent?

Feel free to send us a message here and we will get back to you